Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001071BKPyvENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS46001465BKPyvENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS10017814HBVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS10038012HBVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS10033573HBVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS30008064HIVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS30003350HIVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS30008065HIVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS30019504HIVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS30054554HIVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TCGA Plot Options
Drug Information
GeneIFNAR1
DrugBank IDDB00034
Drug NameInterferon alfa-2a
Target IDBE0000661
UniProt IDP17181
Regulation Type
PubMed IDs15898717; 18230610
CitationsDhalluin C, Ross A, Huber W, Gerber P, Brugger D, Gsell B, Senn H: Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2. Bioconjug Chem. 2005 May-Jun;16(3):518-27.@@Cironi P, Swinburne IA, Silver PA: Enhancement of cell type specificity by quantitative modulation of a chimeric ligand. J Biol Chem. 2008 Mar 28;283(13):8469-76. doi: 10.1074/jbc.M708502200. Epub 2008 Jan 29.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA164779048
ChEMBL